Tyrosine and serine/threonine signal-transduction...
Artículos Científicos en Ingles
Artículos Científicos RSS JASN
Artículos Científicos RSS ASN
Initial diagnosis of acute kidney injury may be inaccurate for many patients, study suggestsResearchers from Columbia University Medical Center have... | HIV+ KIDNEY FAILURE PATIENTS FACE HURDLES IN RECEIVING NECESSARY TRANSPLANTSEfforts are needed to understand disparities in access... | Diabetic Kidney Disease Is Decoded, Offering New Avenues for Diagnosis and TreatmentMount Sinai researchers say their study represents hope... |
Discovery could help doctors to spot cardiovascular disease at an earlier stageScreening methods for cardiovascular diseases such as... | Excess lipoproteins, fatty acids may be linked to chronic kidney stones in childrenA unique study recently published in the authoritative... | LIMITING SALT CONSUMPTION LOWERS BLOOD PRESSURE IN PATIENTS WITH KIDNEY DISEASEReceiving advice on limiting salt consumption helped... |
DISCOVERY MAY HELP PREVENT TISSUE SCARRING AND REJECTION OF TRANSPLANTED KIDNEYSDuring rejection of a transplanted kidney, certain... |
Artículos Científicos RSS AJKD
Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi SurveySurvival and quality of life for patients on... | Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKDErythropoiesis-stimulating agents (ESAs) increase... | BRAF Signaling Pathway Inhibition, Podocyte Injury, and Nephrotic SyndromeDabrafenib and trametinib, BRAF and MEK inhibitors,... |
System-Level Barriers and Facilitators for Foregoing or Withdrawing Dialysis: A Qualitative Study of Nephrologists in the United States and EnglandDespite a growing body of literature suggesting that... | In Reply to ‘Long-term Outcomes of Survivors of Acute Kidney Injury Stage 3’Dr Schiffl1 recognizes several important findings in our... | Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized TrialsIntravenous (IV) cyclophosphamide has been first-line... |
